The Influence of Aspirin on Early Development of Acute Respiratory Distress Syndrome in Severe Cerebrovascular Disease

doi:10.3969/j.issn.1673-5765.2017.09.003

Abstract

Abstract:

Objective To investigate the influence of Aspirin on the early development of acute respiratory distress syndrome (ARDS) incidence rate in patients with severe cerebrovascular disease. Methods This was a prospective cohort study. A total of 309 patients admitted to the neurologic intensive care unit (NICU) of our hospital within 48 hours after onset of severe cerebrovascular disease with a Glasgow Coma Scale (GCS) score ≤8 points were consecutively enrolled. Subjects of entry included sex, age, medical history, medication preceding onset, baseline score of GCS, primary disease, whether the patient underwent anesthesia and/or received craniotomy, early ARDS occurrence, mechanical ventilation time, length of stay in NICU, mortality rate, etc. The ARDS incidence rates of two groups were compared. Meanwhile, the clinical factors of patients of ARDS and non-ARDS groups were compared. Results There was a significant reduction of ARDS incidence rate in aspirin group (n =106) as opposed to non-aspirin group (n =203) 20.8% vs 30.5% (P =0.045). Patients of the aspirin group had a higher average age[(62.41±10.69) vs (57.40±14.80), P =0.002], a larger percentage of combined hypertension (50.9% vs 38.4%, P =0.035), more coronary heart disease (31.1% vs 20.2%, P =0.032), and higher rate of taking statins (26.4% vs 8.4%, P =0.002). Ischemic stroke accounted for a larger proportion of the primary disease in this group. As opposed to non-ARDS group (223 cases), ARDS group (n =86) had lower GCS scores [(3.87±1.61) vs (6.48±1.51), P =0.043], less mechanical ventilation time [6 (5-8)d vs 0 (0-3)d, P =0.001], and required longer NICU stay [8 (6-10)d vs 3 (2-4)d, P =0.001], but had no significant difference in mortality rate. Conclusion Regular use of aspirin can reduce early ARDS incidence rate in severe cerebrovascular diseases, but cannot reduce mechanical ventilation time, duration of stay in NICU or morality rate.

Key words: Severe; Cerebrovascular disease; Acute Respiratory Distress Syndrome; Aspirin

摘要：

目的探讨服用阿司匹林对重症脑血管病早期急性呼吸窘迫综合征（acute respiratory distress syndrome，ARDS）发生率的影响。方法该研究为前瞻性队列研究，连续纳入收住首都医科大学附属北京天坛医院脑血管病中心神经重症监护室（neurologic intensive care unit，NICU）的急性重症脑血管病[发病48 h内格拉斯哥昏迷评分（Glasgow coma scale，GCS）≤8分]的309例患者，登记患者的性别、年龄、既往病史、卒中前服药史、基线GCS评分、原发病、是否进行全身麻醉及开颅手术、是否早期发生ARDS以及机械通气时间、NICU住院时间、死亡率等。按照患者发病前是否规律服用阿司匹林分为阿司匹林组和非阿司匹林组，对比两组患者早期ARDS发生率。同时对发生ARDS的患者与非ARDS患者两组的临床因素进行比较。结果阿司匹林组（106例）较非阿司匹林组（203例）的ARDS发生率（20.8% vs 30.5%，P =0.045）显著减低，阿司匹林组患者的平均年龄较大（[ 62.41±10.69）岁vs（57.40±14.80）岁，P=0.002]、合并高血压（50.9% vs 38.4%，P =0.035）、冠状动脉粥样硬化性心脏病（31.1% vs 20.2%，P =0.032）、同时服用他汀类药物的比例（26.4% vs 8.4%，P =0.002）也较高，原发病构成比例中缺血性卒中的比例更高。ARDS组（86例）与非ARDS（223例）组比较，患者入院时GCS评分（[ 3.87±1.61）vs（6.48±1.51）， P =0.043]较低、机械通气时间[6（5～8）d vs 0（0～3）d，P =0.001]和NI CU住院时间[8（6～10）d vs 3 （2～4）d，P =0.001]较长，但死亡率无显著差异。结论发病前规律服用阿司匹林能够减少重症脑血管病患者早期ARDS的发生率，但不能降低机械通气时间、NICU住院时间及死亡率。

关键词: 重症; 脑血管病; 急性呼吸窘迫综合征; 阿司匹林

WEN Miao, YANG Bo, WEI Na, ZHANG Jing, YAN Jing, PU Yue-Hua, YANG Zhong-Hua. The Influence of Aspirin on Early Development of Acute Respiratory Distress Syndrome in Severe Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2017, 12(09): 776-780.

温淼，杨波，魏娜，张婧，闫婧，濮月华，杨中华. 阿司匹林对重症脑血管病早期发生急性呼吸窘迫综合征的影响[J]. 中国卒中杂志, 2017, 12(09): 776-780.

References

[1] MARK E，MIKKELSEN，CHIRAG V，et al. The

epidemiology of acute respiratory distress syndrome

in patients presenting to the emergency department

with severe sepsis[J]. Shock，2013，40（5）：375-381.

[2] RANIERI V M，RUBENFELD G D，THOMPSON

B T，et al. Acute respiratory distress syndrome

（ARDS）：The Berlin Definition[J]. JAMA，2012，

307（23）：2526-2533.

[3] ERICKSON S E，MARTIN G S，DAVIS J L，et al.

NIH NHLBI ARDS Network：Recent trends in acute

lung injury mortality：1996-2005[J]. Crit CareMed，

2009; 37（5）：1574-1579.

[4] AVECILLAS J F，FREIRE A X，ARROLIGA A C.

Clinical epidemiology of acute lung injury and acute

respiratory distress syndrome：Incidence，diagnosis，

and outcomes[J]. Clin Chest Med，2006，27（4）：549-

557.

[5] RUBENFELD G D，HERRIDGE M S. Epidemiology and

outcomes of acute lung injury[J]. Chest，2007，131（2）：

554-562.

[6] JEPSEN S，HERLEVSEN P，KNUDSEN P，et al.

Antioxidant treatment withN-acetylcysteine during

adult respiratory distress syndrome：A prospective，

randomized，placebo-controlled study[J]. Crit Care Med，

1992，20（7）：918-923.

[7] HE ARDSNETWORK. Ketoconazole for early treatment

of acute lung injury and acute respiratory distress

syndrome：A randomized controlled trial[J]. JAMA，

2000，283（15）：1995-2002.

[8] [No authors listed]. Randomized，placebo-controlled trial

of lisofylline for early treatment of acute lung injury and

acute respiratory distress syndrome[J]. Crit Care Med，

2002，30（1）：1-6.

[9] MEADE M O，JACKA M J，COOK D J，et al. Canadian

Critical Care Trials Group：Survey of interventions for

the prevention and treatment of acute respiratory distress

syndrome[J]. Crit Care Med，2004，32（4）：946-954.

[10] ZARBOCK A，SINGBARTL K，LEY K. Complete

reversal of acid-induced acute lung injury by blocking

of platelet-neutrophil aggregation[J]. J Clin Invest，2006，

116（12）：3211-3219.

[11] KIEFMANN R，HECKEL K，SCHENKAT S，et al.

Platelet-endothelial cell interaction in pulmonary microcirculation：

The role of PARS[J]. Thromb Haemost，2004，

91（4）：761-770.

[12] KIEFMANN R，HECKEL K，SCHENKAT S，et al.

Role of p-selectin in platelet sequestration in pulmonary

capillaries during endotoxemia[J]. J Vasc Res，2006，43

（5）：473-481.

[13] ZARBOCK A，LEY K. The role of platelets in acute lung

injury（ALI）[J]. Front Biosci（Landmark Ed），2009，14

（1）：150-158.

[14] CAUDRILLIER A，KESSENBROCK K，GILLISS BM，

et al. Platelets induce neutrophil extracellular traps in

transfusion-related acute lung injury[J]. J Clin Invest，

2012，122（7）：2661-2671.

[15] LOONEY M R，NGUYEN J X，HU Y，et al. Platelet

depletion and aspirin treatment protect mice in a twoevent

model of transfusion-related acute lung injury[J]. J

Clin Invest，2009，119（11）：3450-3461.

[16] CHEN Z T，LI S L，CAI E Q，et al. LPS induces

pulmonary intravascular macrophages producing

inflammatory mediators via activating NF-kappaB[J]. J

Cell Biochem，2003，89（6）：1206-1214.

[17] TUINMAN P R，MÜLLER M C，JONGSMA G，et al.

High-dose acetylsalicylic acid is superior to low-dose as

well as to clopidogrel in preventing lipopolysaccharideinduced

lung injury in mice[J]. Shock，2013，40（4）：

334-338.

[18] KARIO K，EGUCHI K，HOSHIDE S，et al. U-curve

relationship between orthostatic blood pressure change

and silent cerebrovascular disease in elderly hypertensives：

Orthostatic hypertension as a new cardiovascular risk

factor[J]. J Am Coll Cardiol，2002，40（1）：133-141.

[19] EICKMEIER O，SEKI H，HAWORTH O，et al. Aspirintriggered

resolvin D1 reduces mucosal inflammation

and promotes resolution in a murine model of acute lung

injury[J]. Mucosal Immunol，2013，6（2）：256-266.

[20] PANKA B A，DE GROOTH H J，SPOELSTRA-DE

MAN A M，et al. Prevention or treatment of ards with

aspirin：A Review of preclinical models and metaanalysis

of clinical studies[J]. Shock，2017，47（1）：13-21.

[21] HAMID U，KRASNODEMBSKAYA A，FITZGERALD

M，et al. Aspirin reduces lipopolysaccharide-induced

pulmonary inflammation in human models of ARDS[J].

Thorax，2017，DOI：10. 1136/thoraxjnl-2016-208571.

[22] DAS U N. Combination of aspirin with essential fatty

acids is superior to aspirin alone to prevent or ameliorate

sepsis or ARDS[J]. Lipids Health Dis，2016，15（1）：206.

[23] KOR D J，CARTER R E，PARK P K，et al. Banner-

Goodspeed VM5，Hinds R1，Talmor D6，Gajic O7，Ware

LB8，Gong MN9；US Critical Illness and Injury Trials

Group：Lung Injury Prevention with Aspirin Study Group

（USCIITG：LIPS-A）. Effect of aspirin on development

of ARDS in at-risk patients presenting to the emergency

department：The LIPS-A randomized clinical trial[J].

JAMA，2016，315（22）：2406-2414.

[24] REILLY J P，CHRISTIE J D. Is It Possible to Prevent

ARDS?[J] JAMA，2016，315（22）：2403-2405.

[25] WEI CHEN M D，DAVID R，JANZ M D，et al.

Prehospital aspirin use is associated with reduced risk

of acute respiratory distress syndrome in critically III

patients：A propensity-adjusted analysis[J]. Crit Care

Med，2015，43（4）：801-806.

[26] O’NEAL H R JR，KOYAMA T，KOEHLER E A，et

al. Prehospital statin and aspirin use and the prevalence

of severe sepsis and acute lung injury/acute respiratory

distress syndrome[J]. Crit Care Med，2011，39（6)：1343-

1350.